| |
| |
|
| Insider
Information: |
Kirk Randal J |
| Relationship: |
10% Owner |
| City: |
Radford |
| State: |
VA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
3,684,697 |
|
|
Indirect Shares
|
67,796,291 |
|
|
| Direct
Value |
$156,195,711 |
|
|
|
Indirect Value
|
$358,769,739 |
|
|
| Total
Shares |
71,480,988 |
|
|
| Total
Value |
$514,965,450 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
14
|
0
|
|
Stock
price went up :
|
6
|
0
|
| Stock
price went down : |
8
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 45.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLDA |
Clinical Data Inc |
Director |
– • • |
2003-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
615,050 |
1,048,191 |
|
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2003-11-10 |
4 |
A |
$0.00 |
$0 |
I/I |
1,411,600 |
112,890 |
|
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2005-11-17 |
4 |
A |
$19.56 |
$6,000,014 |
I/I |
306,710 |
102,236 |
|
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2005-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
1,056,191 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-02-09 |
4 |
A |
$23.40 |
$3,588,507 |
I/I |
153,355 |
153,353 |
|
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-06-13 |
4 |
A |
$16.27 |
$5,999,996 |
I/I |
368,720 |
429,912 |
|
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
10,800 |
1,066,991 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2007-05-15 |
4 |
A |
$10.37 |
$155,550 |
D/D |
15,000 |
355,000 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2007-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,460 |
1,620,946 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
370,000 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2008-09-23 |
4 |
A |
$0.00 |
$0 |
D/D |
18,334 |
1,639,280 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2008-09-26 |
4 |
A |
$16.50 |
$18,000,003 |
I/I |
1,090,744 |
24,240 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2008-09-26 |
4 |
A |
$16.50 |
$6,999,997 |
D/D |
424,178 |
2,063,458 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2009-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
3,390,000 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2009-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
2,311,487 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2010-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
3,410,000 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2010-09-16 |
4 |
A |
$0.00 |
$0 |
D/D |
15,200 |
2,326,687 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2011-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
3,430,000 |
0 |
- |
|
| PRPO |
Precipio Inc |
10% Owner |
– – • |
2012-02-03 |
4 |
A |
$0.00 |
$0 |
I/I |
3,000,000 |
649,181 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2012-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
3,450,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2013-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
3,470,000 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2013-08-13 |
4 |
A |
$0.00 |
$1,501,600 |
I/I |
1,696,140 |
76,611 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2013-08-13 |
4 |
A |
$0.00 |
$4,788,448 |
I/I |
5,399,630 |
131,081 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2013-08-13 |
4 |
A |
$0.00 |
$1,579,760 |
I/I |
1,880,737 |
73,668 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2014-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
24,876 |
3,504,876 |
0 |
- |
|
271 Records found
|
|
Page 1 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
